By stripping waste and other non-value-added steps from the production process, lean manufacturing has saved companies billions
of dollars. But why stop there? If a company is using traditional testing methods to release its products to market, the adoption
of rapid microbial methods (RMMs) is one of the most important additions a company can make to its lean initiatives.
THE VALUE OF RAPID METHODS
Lean quality is achieved by extending the principles of lean manufacturing to microbial testing. RMMs are being adopted by
increasing numbers of pharmaceutical companies around the world to reduce lead times while ensuring product safety. Implementing
rapid methods can unlock huge savings by shortening microbial hold times to just 24 hours for microbial limits, and cutting
sterility testing time by more than 50%. This translates into an average 5–year net present value savings of $500,000 or more
Improved efficiency also reduces recovery time in the event of contamination. During production, when so much is at risk,
the benefits of rapid methods are doubled. The faster that corrective action can be initiated, the faster recovery can occur,
which reduces the potential impact on customer relationships and the bottom line.
PHOTO COURTESY OF THE AUTHOR
HOW RAPID METHODS WORK
Products that are susceptible to microbial contamination but expected to be shipped contamination free are screened before
being released into distribution. That screening adds multiple days to the production cycle and extends lead times. Microscreening
typically takes 3–7 days for microlimits testing and 14 days or more for sterility. That's a long time to wait when there
is a good production process in place that is turning out products free from bioburden almost all the time. The wait time
is frustrating, and expensive.
Well-validated, rapid methods are just as effective as traditional microbiological methods, only faster. Results can be delivered
in as few as 24 hours using a rapid method featuring adenylate kinase (AK). AK-amplified bioluminescence combines the use
of adenosine triphosphate (ATP), the gold standard of rapid detection methods, with a patented enzyme technology to deliver
accurate results quickly.
All living organisms contain the compound ATP as a vital part of their energy metabolism. In the standard bioluminescence
test, when ATP is detected, a reaction occurs that generates a photon of yellow-green light, similar to that of a firefly.
It is a very sensitive technique, but limited by the fact that an organism contains only a small amount of the metabolite
Adenylate kinase (AK) is another vital part of energy metabolism. When supplied with an excess of ADP (adenosine diphosphate),
AK acts as a catalyst, converting ADP into ATP. Because AK is an enzyme rather than a metabolite, it can be harnessed to generate
almost unlimited amounts of its product. After 25 minutes, for example, the amount of ATP can be 1000 times greater than that
which the organism originally contained. As a result of this amplification and the reduced dependence upon microbial growth
for detection, AK-amplified bioluminescence provides faster results when screening for microbial contamination.